hexamethonium has been researched along with icatibant in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schoemaker, RG; van Heijningen, CL | 1 |
| Dendorfer, A; Dominiak, P; Heidbreder, M; Nienstedt, J; Schneider, K; Wolfrum, S | 1 |
2 other study(ies) available for hexamethonium and icatibant
| Article | Year |
|---|---|
Bradykinin mediates cardiac preconditioning at a distance.
Topics: Adrenergic beta-Antagonists; Animals; Bradykinin; Bradykinin Receptor Antagonists; Coronary Vessels; Dose-Response Relationship, Drug; Heart; Hexamethonium; Infusions, Intra-Arterial; Ischemic Preconditioning, Myocardial; Linear Models; Male; Mesenteric Arteries; Myocardial Ischemia; Myocardium; Nicotinic Antagonists; Rats; Rats, Wistar; Receptor, Bradykinin B2; Receptors, Bradykinin; Survival Rate | 2000 |
Remote preconditioning protects the heart by activating myocardial PKCepsilon-isoform.
Topics: Adrenergic beta-Antagonists; Alkaloids; Animals; Benzophenanthridines; Bradykinin; Enzyme Activation; Enzyme Inhibitors; Ganglionic Blockers; Hexamethonium; Intestines; Ischemic Preconditioning; Ischemic Preconditioning, Myocardial; Isoenzymes; Male; Myocardial Infarction; Myocardium; Phenanthridines; Protein Kinase C; Random Allocation; Rats; Rats, Wistar | 2002 |